Skip to main content
Top
Published in: Lung 2/2021

Open Access 01-04-2021 | COPD Exacerbation | COUGH and COPD

Domiciliary Cough Monitoring for the Prediction of COPD Exacerbations

Authors: Michael G. Crooks, Albertus C. den Brinker, Susannah Thackray-Nocera, Ralph van Dinther, Caroline E. Wright, Alyn H. Morice

Published in: Lung | Issue 2/2021

Login to get access

Abstract

Introduction

Acute exacerbations of COPD (AE-COPD) are a leading cause of health service utilisation and are associated with morbidity and mortality. Identifying the prodrome of AE-COPD by monitoring symptoms and physiological parameters (telemonitoring) has proven disappointing and false alerts limit clinical utility. We report objective monitoring of cough counts around AE-COPD and the performance of a novel alert system identifying meaningful change in cough frequency.

Methods

This prospective longitudinal study of cough monitoring included chronic obstructive pulmonary disease (COPD) patients experienced in telemonitoring that had two or more AE-COPD in the past year. Participants underwent cough monitoring and completed a daily questionnaire for 90 days. The automated system identified deteriorating trends in cough and this was compared with alerts generated by an established telemonitoring questionnaire.

Results

28 patients [median age 66 (range 46–86), mean FEV-1% predicted 36% (SD 18%)] completed the study and had a total of 58 exacerbations (43 moderate and 15 severe). Alerts based on cough monitoring were generated mean 3.4 days before 45% of AE-COPD with one false alert every 100 days. In contrast, questionnaire-based alerts occurred in the prodrome of 88% of AE-COPD with one false alert every 10 days.

Conclusion

An alert system based on cough frequency alone predicted 45% AE-COPD; the low false alert rate with cough monitoring suggests it is a practical and clinically relevant tool. In contrast, the utility of questionnaire-based symptom monitoring is limited by frequent false alerts.
Literature
1.
go back to reference Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2095–2128CrossRef Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2095–2128CrossRef
2.
go back to reference Anzueto A (2010) Impact of exacerbations on COPD. Eur Respir Rev 19(116):113–118CrossRef Anzueto A (2010) Impact of exacerbations on COPD. Eur Respir Rev 19(116):113–118CrossRef
3.
go back to reference Pinnock H, Hanley J, McCloughan L, Todd A, Krishan A, Lewis S et al (2013) Effectiveness of telemonitoring integrated into existing clinical services on hospital admission for exacerbation of chronic obstructive pulmonary disease: researcher blind, multicentre, randomised controlled trial. BMJ 347:f6070CrossRef Pinnock H, Hanley J, McCloughan L, Todd A, Krishan A, Lewis S et al (2013) Effectiveness of telemonitoring integrated into existing clinical services on hospital admission for exacerbation of chronic obstructive pulmonary disease: researcher blind, multicentre, randomised controlled trial. BMJ 347:f6070CrossRef
4.
go back to reference Walker PP, Pompilio PP, Zanaboni P, Bergmo TS, Prikk K, Malinovschi A et al (2018) Telemonitoring in chronic obstructive pulmonary disease (CHROMED). A randomized clinical trial. Am J Respir Crit Care Med 198(5):620–628CrossRef Walker PP, Pompilio PP, Zanaboni P, Bergmo TS, Prikk K, Malinovschi A et al (2018) Telemonitoring in chronic obstructive pulmonary disease (CHROMED). A randomized clinical trial. Am J Respir Crit Care Med 198(5):620–628CrossRef
5.
go back to reference Vianello A, Fusello M, Gubian L, Rinaldo C, Dario C, Concas A et al (2016) Home telemonitoring for patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled trial. BMC Pulm Med 16(1):157CrossRef Vianello A, Fusello M, Gubian L, Rinaldo C, Dario C, Concas A et al (2016) Home telemonitoring for patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled trial. BMC Pulm Med 16(1):157CrossRef
6.
go back to reference Chatwin M, Hawkins G, Panicchia L, Woods A, Hanak A, Lucas R et al (2016) Randomised crossover trial of telemonitoring in chronic respiratory patients (TeleCRAFT trial). Thorax 71(4):305–311CrossRef Chatwin M, Hawkins G, Panicchia L, Woods A, Hanak A, Lucas R et al (2016) Randomised crossover trial of telemonitoring in chronic respiratory patients (TeleCRAFT trial). Thorax 71(4):305–311CrossRef
7.
go back to reference de Oliveira JC, de Carvalho AI, de Oliveira Beloto AC, Santos IR, Filho FS, Sampaio LM et al (2013) Clinical significance in COPD patients followed in a real practice. Multidiscip Respir Med 8(1):43CrossRef de Oliveira JC, de Carvalho AI, de Oliveira Beloto AC, Santos IR, Filho FS, Sampaio LM et al (2013) Clinical significance in COPD patients followed in a real practice. Multidiscip Respir Med 8(1):43CrossRef
8.
go back to reference Kessler R, Partridge MR, Miravitlles M, Cazzola M, Vogelmeier C, Leynaud D et al (2011) Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J 37(2):264–272CrossRef Kessler R, Partridge MR, Miravitlles M, Cazzola M, Vogelmeier C, Leynaud D et al (2011) Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J 37(2):264–272CrossRef
9.
go back to reference Ekberg-Aronsson M, Pehrsson K, Nilsson JA, Nilsson PM, Lofdahl CG (2005) Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 6:98CrossRef Ekberg-Aronsson M, Pehrsson K, Nilsson JA, Nilsson PM, Lofdahl CG (2005) Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 6:98CrossRef
10.
go back to reference Calverley P, Pauwels Dagger R, Lofdahl CG, Svensson K, Higenbottam T, Carlsson LG et al (2005) Relationship between respiratory symptoms and medical treatment in exacerbations of COPD. Eur Respir J 26(3):406–413CrossRef Calverley P, Pauwels Dagger R, Lofdahl CG, Svensson K, Higenbottam T, Carlsson LG et al (2005) Relationship between respiratory symptoms and medical treatment in exacerbations of COPD. Eur Respir J 26(3):406–413CrossRef
11.
go back to reference Crooks MG, den Brinker A, Hayman Y, Williamson JD, Innes A, Wright CE et al (2017) Continuous cough monitoring using ambient sound recording during convalescence from a COPD exacerbation. Lung 195(3):289–294CrossRef Crooks MG, den Brinker A, Hayman Y, Williamson JD, Innes A, Wright CE et al (2017) Continuous cough monitoring using ambient sound recording during convalescence from a COPD exacerbation. Lung 195(3):289–294CrossRef
12.
go back to reference Crooks MG, Hayman Y, Innes A, Williamson J, Wright CE, Morice AH (2016) Objective measurement of cough frequency during COPD exacerbation convalescence. Lung 194(1):117–120CrossRef Crooks MG, Hayman Y, Innes A, Williamson J, Wright CE, Morice AH (2016) Objective measurement of cough frequency during COPD exacerbation convalescence. Lung 194(1):117–120CrossRef
13.
go back to reference den Brinker AC, van Dinther R, Crooks MG, Thackray-Nocera S, Morice AH (2021) Alert system design based on experimental findings from long-term unobtrusive monitoring in COPD. Biomed Signal Process Control 63:102205CrossRef den Brinker AC, van Dinther R, Crooks MG, Thackray-Nocera S, Morice AH (2021) Alert system design based on experimental findings from long-term unobtrusive monitoring in COPD. Biomed Signal Process Control 63:102205CrossRef
14.
go back to reference den Brinker AC, Coman M, Ouweltjes O, Thackray-Nocera S, Crooks MG, Morice AH (2020) Performance requirements for cough classifiers in real-world applications. In: EUSIPCO, 28th European Signal Processing Conference (In Print) den Brinker AC, Coman M, Ouweltjes O, Thackray-Nocera S, Crooks MG, Morice AH (2020) Performance requirements for cough classifiers in real-world applications. In: EUSIPCO, 28th European Signal Processing Conference (In Print)
15.
go back to reference Wedzicha JA, Banerji D, Chapman KR, Vestbo J, Roche N, Ayers RT et al (2016) Indacaterol-glycopyrronium versus salmeterol-fluticasone for COPD. N Engl J Med 374(23):2222–2234CrossRef Wedzicha JA, Banerji D, Chapman KR, Vestbo J, Roche N, Ayers RT et al (2016) Indacaterol-glycopyrronium versus salmeterol-fluticasone for COPD. N Engl J Med 374(23):2222–2234CrossRef
Metadata
Title
Domiciliary Cough Monitoring for the Prediction of COPD Exacerbations
Authors
Michael G. Crooks
Albertus C. den Brinker
Susannah Thackray-Nocera
Ralph van Dinther
Caroline E. Wright
Alyn H. Morice
Publication date
01-04-2021
Publisher
Springer US
Published in
Lung / Issue 2/2021
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-021-00435-9

Other articles of this Issue 2/2021

Lung 2/2021 Go to the issue

INHALED IRRITANT-INDUCED PULMONARY DISEASE

Irritant-induced Asthma Caused by Aerotoxic Syndrome

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.